Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 112

    1.

    Antiviral treatment and prophylaxis of influenza virus in children.

    Nayak JL, Treanor JJ.

    Pediatr Ann. 2009 Dec;38(12):667-74. doi: 10.3928/00904481-20091117-07. No abstract available. PMID: 20000234 [PubMed - in process]Related articles

    2.

    Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection.

    Bernard MP, Bancos S, Chapman TJ, Ryan EP, Treanor JJ, Rose RC, Topham DJ, Phipps RP.

    Vaccine. . [Epub ahead of print]PMID: 19941994 [PubMed - as supplied by publisher]Related articles

    3.

    Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old.

    Keitel WA, Treanor JJ, El Sahly HM, Gilbert A, Meyer AL, Patriarca PA, Cox MM.

    Vaccine. 2009 Dec 11;28(2):379-85. Epub 2009 Oct 29.PMID: 19879222 [PubMed - in process]Related articles

    4.

    Public health. Rethinking influenza.

    Rappuoli R, Del Giudice G, Nabel GJ, Osterhaus AD, Robinson R, Salisbury D, Stöhr K, Treanor JJ.

    Science. 2009 Oct 2;326(5949):50. No abstract available. PMID: 19797644 [PubMed - indexed for MEDLINE]Related articles

    5.

    Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.

    Zinckgraf JW, Sposato M, Zielinski V, Powell D, Treanor JJ, von Hofe E.

    Vaccine. 2009 Aug 27;27(39):5393-401. Epub 2009 Jul 9.PMID: 19596415 [PubMed - indexed for MEDLINE]Related articles

    6.

    Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults.

    Brady RC, Treanor JJ, Atmar RL, Keitel WA, Edelman R, Chen WH, Winokur P, Belshe R, Graham IL, Noah DL, Guo K, Hill H.

    Vaccine. 2009 Aug 13;27(37):5091-5. Epub 2009 Jul 3.PMID: 19577636 [PubMed - indexed for MEDLINE]Related articles

    7.

    Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

    Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ.

    J Infect Dis. 2009 Jul 15;200(2):172-80.PMID: 19508159 [PubMed - indexed for MEDLINE]Related articles

    8.

    Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults.

    Keitel WA, Treanor JJ, El Sahly HM, Evans TG, Kopper S, Whitlow V, Selinsky C, Kaslow DC, Rolland A, Smith LR, Lalor PA.

    Hum Vaccin. 2009 Aug;5(8):536-44. Epub 2009 Aug 14.PMID: 19458488 [PubMed - in process]Related articles

    9.

    The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals.

    Crompton PD, Mircetic M, Weiss G, Baughman A, Huang CY, Topham DJ, Treanor JJ, Sanz I, Lee FE, Durbin AP, Miura K, Narum DL, Ellis RD, Malkin E, Mullen GE, Miller LH, Martin LB, Pierce SK.

    J Immunol. 2009 Mar 1;182(5):3318-26.PMID: 19234231 [PubMed - indexed for MEDLINE]Related articles

    10.

    Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.

    Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ; Walter Reed Health Care System Influenza Vaccine Consortium.

    Arch Intern Med. 2008 Dec 8;168(22):2405-14.PMID: 19064822 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Differential effects of pneumococcal vaccines against serotypes 6A and 6C.

    Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B, Shelly MA, Mahon BE, Nahm MH; Active Bacterial Core Surveillance Team.

    J Infect Dis. 2008 Dec 15;198(12):1818-22.PMID: 18983249 [PubMed - indexed for MEDLINE]Related articles

    12.

    Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

    Keitel WA, Campbell JD, Treanor JJ, Walter EB, Patel SM, He F, Noah DL, Hill H.

    J Infect Dis. 2008 Nov 1;198(9):1309-16.PMID: 18808338 [PubMed - indexed for MEDLINE]Related articles

    13.

    Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists.

    Stec MM, Bo Y, Chakrabarti PP, Liao L, Ncube M, Tamayo N, Tamir R, Gavva NR, Treanor JJ, Norman MH.

    Bioorg Med Chem Lett. 2008 Sep 15;18(18):5118-22. Epub 2008 Jul 31.PMID: 18722118 [PubMed - indexed for MEDLINE]Related articles

    14.

    Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

    Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ.

    J Infect Dis. 2008 Sep 1;198(5):635-41.PMID: 18694338 [PubMed - indexed for MEDLINE]Related articles

    15.

    Objective and subjective socioeconomic status and susceptibility to the common cold.

    Cohen S, Alper CM, Doyle WJ, Adler N, Treanor JJ, Turner RB.

    Health Psychol. 2008 Mar;27(2):268-74.PMID: 18377146 [PubMed - indexed for MEDLINE]Related articles

    16.

    Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.

    Gavva NR, Treanor JJ, Garami A, Fang L, Surapaneni S, Akrami A, Alvarez F, Bak A, Darling M, Gore A, Jang GR, Kesslak JP, Ni L, Norman MH, Palluconi G, Rose MJ, Salfi M, Tan E, Romanovsky AA, Banfield C, Davar G.

    Pain. 2008 May;136(1-2):202-10. Epub 2008 Mar 11.PMID: 18337008 [PubMed - indexed for MEDLINE]Related articles

    17.

    4-Aminopyrimidine tetrahydronaphthols: a series of novel vanilloid receptor-1 antagonists with improved solubility properties.

    Doherty EM, Retz D, Gavva NR, Tamir R, Treanor JJ, Norman MH.

    Bioorg Med Chem Lett. 2008 Mar 15;18(6):1830-4. Epub 2008 Feb 13.PMID: 18299195 [PubMed - indexed for MEDLINE]Related articles

    18.

    Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans.

    Zangwill KM, Treanor JJ, Campbell JD, Noah DL, Ryea J.

    J Infect Dis. 2008 Feb 15;197(4):580-3.PMID: 18237269 [PubMed - indexed for MEDLINE]Related articles

    19.

    Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility.

    Wang X, Chakrabarti PP, Ognyanov VI, Pettus LH, Tamir R, Tan H, Tang P, Treanor JJ, Gavva NR, Norman MH.

    Bioorg Med Chem Lett. 2007 Dec 1;17(23):6539-45. Epub 2007 Oct 15.PMID: 17937985 [PubMed - indexed for MEDLINE]Related articles

    20.

    Structure-activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists.

    Gore VK, Ma VV, Tamir R, Gavva NR, Treanor JJ, Norman MH.

    Bioorg Med Chem Lett. 2007 Nov 1;17(21):5825-30. Epub 2007 Aug 25.PMID: 17851073 [PubMed - indexed for MEDLINE]Related articles

    21.

    Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.

    Gavva NR, Bannon AW, Hovland DN Jr, Lehto SG, Klionsky L, Surapaneni S, Immke DC, Henley C, Arik L, Bak A, Davis J, Ernst N, Hever G, Kuang R, Shi L, Tamir R, Wang J, Wang W, Zajic G, Zhu D, Norman MH, Louis JC, Magal E, Treanor JJ.

    J Pharmacol Exp Ther. 2007 Oct;323(1):128-37. Epub 2007 Jul 25.PMID: 17652633 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors.

    Steiner AA, Turek VF, Almeida MC, Burmeister JJ, Oliveira DL, Roberts JL, Bannon AW, Norman MH, Louis JC, Treanor JJ, Gavva NR, Romanovsky AA.

    J Neurosci. 2007 Jul 11;27(28):7459-68.PMID: 17626206 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties.

    Wang HL, Katon J, Balan C, Bannon AW, Bernard C, Doherty EM, Dominguez C, Gavva NR, Gore V, Ma V, Nishimura N, Surapaneni S, Tang P, Tamir R, Thiel O, Treanor JJ, Norman MH.

    J Med Chem. 2007 Jul 26;50(15):3528-39. Epub 2007 Jun 22.PMID: 17585751 [PubMed - indexed for MEDLINE]Related articles

    24.

    Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.

    Doherty EM, Fotsch C, Bannon AW, Bo Y, Chen N, Dominguez C, Falsey J, Gavva NR, Katon J, Nixey T, Ognyanov VI, Pettus L, Rzasa RM, Stec M, Surapaneni S, Tamir R, Zhu J, Treanor JJ, Norman MH.

    J Med Chem. 2007 Jul 26;50(15):3515-27. Epub 2007 Jun 22.PMID: 17585750 [PubMed - indexed for MEDLINE]Related articles

    25.

    Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.

    Norman MH, Zhu J, Fotsch C, Bo Y, Chen N, Chakrabarti P, Doherty EM, Gavva NR, Nishimura N, Nixey T, Ognyanov VI, Rzasa RM, Stec M, Surapaneni S, Tamir R, Viswanadhan VN, Treanor JJ.

    J Med Chem. 2007 Jul 26;50(15):3497-514. Epub 2007 Jun 22.PMID: 17585749 [PubMed - indexed for MEDLINE]Related articles

    26.

    Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial.

    Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, Holden-Wiltse J, Liang H, Gilbert A, Cox M.

    JAMA. 2007 Apr 11;297(14):1577-82.PMID: 17426277 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation.

    Gavva NR, Bannon AW, Surapaneni S, Hovland DN Jr, Lehto SG, Gore A, Juan T, Deng H, Han B, Klionsky L, Kuang R, Le A, Tamir R, Wang J, Youngblood B, Zhu D, Norman MH, Magal E, Treanor JJ, Louis JC.

    J Neurosci. 2007 Mar 28;27(13):3366-74.PMID: 17392452 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

    Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ.

    PLoS Med. 2007 Feb;4(2):e59.PMID: 17298168 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Vaccines for seasonal and pandemic influenza.

    Nichol KL, Treanor JJ.

    J Infect Dis. 2006 Nov 1;194 Suppl 2:S111-8.PMID: 17163383 [PubMed - indexed for MEDLINE]Related articles

    30.

    Positive emotional style predicts resistance to illness after experimental exposure to rhinovirus or influenza a virus.

    Cohen S, Alper CM, Doyle WJ, Treanor JJ, Turner RB.

    Psychosom Med. 2006 Nov-Dec;68(6):809-15. Epub 2006 Nov 13.PMID: 17101814 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Infection-induced proinflammatory cytokines are associated with decreases in positive affect, but not increases in negative affect.

    Janicki-Deverts D, Cohen S, Doyle WJ, Turner RB, Treanor JJ.

    Brain Behav Immun. 2007 Mar;21(3):301-7. Epub 2006 Oct 18.PMID: 17055218 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Rapid licensure of a new, inactivated influenza vaccine in the United States.

    Treanor JJ, Campbell JD, Brady RC, Keitel WA, Drame M, Jain VK, Innis BL.

    Hum Vaccin. 2005 Nov-Dec;1(6):239-44. Epub 2005 Nov 5.PMID: 17012883 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Avian influenza: exploring all the avenues.

    Treanor JJ.

    Ann Intern Med. 2006 Oct 17;145(8):631-2. Epub 2006 Aug 29. No abstract available. PMID: 16940335 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    A polyclonal antibody to the prepore loop of transient receptor potential vanilloid type 1 blocks channel activation.

    Klionsky L, Tamir R, Holzinger B, Bi X, Talvenheimo J, Kim H, Martin F, Louis JC, Treanor JJ, Gavva NR.

    J Pharmacol Exp Ther. 2006 Oct;319(1):192-8. Epub 2006 Jul 14.PMID: 16844842 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazoles.

    Ognyanov VI, Balan C, Bannon AW, Bo Y, Dominguez C, Fotsch C, Gore VK, Klionsky L, Ma VV, Qian YX, Tamir R, Wang X, Xi N, Xu S, Zhu D, Gavva NR, Treanor JJ, Norman MH.

    J Med Chem. 2006 Jun 15;49(12):3719-42.PMID: 16759115 [PubMed - indexed for MEDLINE]Related articles

    36.

    Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.

    Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, Wolff M, She D, Cox MM.

    J Infect Dis. 2006 May 1;193(9):1223-8. Epub 2006 Mar 28.PMID: 16586358 [PubMed - indexed for MEDLINE]Related articles

    37.

    Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

    Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M.

    N Engl J Med. 2006 Mar 30;354(13):1343-51.PMID: 16571878 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Kupffer cell-dependent hepatitis occurs during influenza infection.

    Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, Crispe IN, Topham DJ, Pierce RH.

    Am J Pathol. 2006 Apr;168(4):1169-78; quiz 1404-5.PMID: 16565492 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.

    Wright PF, Karron RA, Madhi SA, Treanor JJ, King JC, O'Shea A, Ikizler MR, Zhu Y, Collins PL, Cutland C, Randolph VB, Deatly AM, Hackell JG, Gruber WC, Murphy BR.

    J Infect Dis. 2006 Feb 15;193(4):573-81. Epub 2006 Jan 19.PMID: 16425137 [PubMed - indexed for MEDLINE]Related articles

    40.

    Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists.

    Xi N, Bo Y, Doherty EM, Fotsch C, Gavva NR, Han N, Hungate RW, Klionsky L, Liu Q, Tamir R, Xu S, Treanor JJ, Norman MH.

    Bioorg Med Chem Lett. 2005 Dec 1;15(23):5211-7. Epub 2005 Oct 3.PMID: 16203144 [PubMed - indexed for MEDLINE]Related articles

    41.

    Fever and progressive respiratory failure in three elderly family members.

    Lee FE, Daigle CC, Urban MA, Metlay LA, Treanor JJ, Trawick DR.

    Chest. 2005 Sep;128(3):1863-4, 1865-7. No abstract available. PMID: 16162796 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Proton activation does not alter antagonist interaction with the capsaicin-binding pocket of TRPV1.

    Gavva NR, Tamir R, Klionsky L, Norman MH, Louis JC, Wild KD, Treanor JJ.

    Mol Pharmacol. 2005 Dec;68(6):1524-33. Epub 2005 Aug 31.PMID: 16135784 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Loneliness, social network size, and immune response to influenza vaccination in college freshmen.

    Pressman SD, Cohen S, Miller GE, Barkin A, Rabin BS, Treanor JJ.

    Health Psychol. 2005 May;24(3):297-306. Erratum in: Health Psychol. 2005 Jul;24(4):348. PMID: 15898866 [PubMed - indexed for MEDLINE]Related articles

    44.

    Discovery of potent, orally available vanilloid receptor-1 antagonists. Structure-activity relationship of N-aryl cinnamides.

    Doherty EM, Fotsch C, Bo Y, Chakrabarti PP, Chen N, Gavva N, Han N, Kelly MG, Kincaid J, Klionsky L, Liu Q, Ognyanov VI, Tamir R, Wang X, Zhu J, Norman MH, Treanor JJ.

    J Med Chem. 2005 Jan 13;48(1):71-90.PMID: 15634002 [PubMed - indexed for MEDLINE]Related articles

    45.

    AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties.

    Gavva NR, Tamir R, Qu Y, Klionsky L, Zhang TJ, Immke D, Wang J, Zhu D, Vanderah TW, Porreca F, Doherty EM, Norman MH, Wild KD, Bannon AW, Louis JC, Treanor JJ.

    J Pharmacol Exp Ther. 2005 Apr;313(1):474-84. Epub 2004 Dec 22.PMID: 15615864 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Experimental infection of humans with A2 respiratory syncytial virus.

    Lee FE, Walsh EE, Falsey AR, Betts RF, Treanor JJ.

    Antiviral Res. 2004 Sep;63(3):191-6.PMID: 15451187 [PubMed - indexed for MEDLINE]Related articles

    47.

    Psychological stress and antibody response to influenza vaccination: when is the critical period for stress, and how does it get inside the body?

    Miller GE, Cohen S, Pressman S, Barkin A, Rabin BS, Treanor JJ.

    Psychosom Med. 2004 Mar-Apr;66(2):215-23.PMID: 15039506 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Molecular determinants of vanilloid sensitivity in TRPV1.

    Gavva NR, Klionsky L, Qu Y, Shi L, Tamir R, Edenson S, Zhang TJ, Viswanadhan VN, Toth A, Pearce LV, Vanderah TW, Porreca F, Blumberg PM, Lile J, Sun Y, Wild K, Louis JC, Treanor JJ.

    J Biol Chem. 2004 May 7;279(19):20283-95. Epub 2004 Mar 2.PMID: 14996838 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Dose-dependent neutralizing-antibody responses to vaccinia.

    Belshe RB, Newman FK, Frey SE, Couch RB, Treanor JJ, Tacket CO, Yan L.

    J Infect Dis. 2004 Feb 1;189(3):493-7. Epub 2004 Jan 23.PMID: 14745707 [PubMed - indexed for MEDLINE]Related articles

    50.

    Introduction.

    Braciale TJ, Treanor JJ.

    Pediatr Infect Dis J. 2004 Jan;23(1 Suppl):S5. No abstract available. PMID: 14730263 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...